Back to Search
Start Over
Roche says Phase II/III tiragolumab study failed in lung cancer
- Source :
- The Fly. July 4, 2024
- Publication Year :
- 2024
-
Abstract
- Genentech, a member of the Roche Group, announced that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq and chemotherapy versus pembrolizumab and chemotherapy as an initial treatment for people [...]
- Subjects :
- Roche Holding AG -- Product development
Tecentriq (Medication) -- Product development
Care and treatment
Product development
Cancer research
Chemotherapy
Biotechnology industries -- Product development
Pembrolizumab
Non-small cell lung cancer -- Care and treatment
Oncology, Experimental
Biotechnology industry -- Product development
Lung cancer, Non-small cell -- Care and treatment
Cancer -- Chemotherapy -- Research
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.800045120